Glucagon-like Peptide Receptor Agonists Improve Bladder Function in Spinal Cord Injury Mice by Inhibiting Neuroinflammation

Sun Y1, gu b1

Research Type

Pure and Applied Science / Translational

Abstract Category

Neurourology

Abstract 22
Neuroscience
Scientific Podium Short Oral Session 3
Wednesday 7th October 2026
10:07 - 10:15
Parallel Hall 4
0.10 Sydney
Capacity: 265
Spinal Cord Injury Voiding Dysfunction Neuropathies: Central
1. Department of Urology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, China.
Presenter
Links

Abstract

Hypothesis / aims of study
Bladder dysfunction following spinal cord injury (SCI) severely compromises patients’ quality of life. Overactivated microglia after SCI intensify their interaction with astrocytes, leading to secondary injury. Glucagon-like peptide-1 receptor (GLP-1R) agonists have been previously verified to exert neuroprotective effects in neurodegenerative diseases. This study aims to investigate the improvement of neurogenic bladder by GLP-1R agonists (GLP-1RA) after spinal cord injury.
Study design, materials and methods
The effects and mechanisms of GLP-1R activation via Exendin-4 (Ex-4) were studied using in vitro models of primary neurons, primary neural stem cells, glial cells, and an SCI mouse model. Microglial polarization and neuroinflammatory levels were detected by Western blotting, flow cytometry, and immunofluorescence. Transwell assays demonstrated that Ex-4 treatment attenuated the neurotoxicity of M1 microglia and inhibited the transformation of reactive astrocytes. Spinal cord pathology, anterograde tracing of the raphe nucleus, retrograde tracing, and urodynamics in mice confirmed enhanced neuroplasticity and improved bladder function in SCI mice following Ex-4 administration.
Results
Flow cytometric analysis of LPS-induced microglia with or without treated  Ex-4 showed a significant increase in the proportion of CD206(+)CD86(-) M2 microglia (13.6%vs45.3%, p value < 0.05). Spinal cord pathology and immunofluorescence revealed reduced neuroinflammation and neuronal death in the spinal cord of SCI mice treated with Ex-4. Compared with the SCI group, Ex-4-treated mice exhibited significant improvements in post-void residual (PVR) (0.2 mLvs0.5 mL, p value< 0.05), maximum detrusor pressure (75 cm H₂O vs 38 cm H₂O, p value< 0.05), and voiding efficiency (16%vs78%, p value < 0.05).
Interpretation of results
Activation of GLP-1R alleviates microglia-induced neuroinflammation by switching microglia from the M1 to the M2 phenotype. In mice, GLP-1R activation effectively attenuates SCI-induced neuronal death and preserves urinary function.
Concluding message
Ex-4 exerts neuroprotective effects by suppressing microglial neuroinflammation. It also promotes neural stem cell differentiation and maintains the survival of relay neurons, showing potential for facilitating functional recovery following spinal cord injury.
Disclosures
Funding National Natural Science Foundation of China. Grant Numbers:81870251 Clinical Trial No Subjects Animal Species Mouse Ethics Committee Ethics Committee of Shanghai Sixth People's Hospital AI For simple textual assistance in writing the abstract manuscript
Citation

Continence 19S (2026) 102499
DOI: 10.1016/j.cont.2026.102499

02/11/2026 00:48:05